Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpendo.00639.2012PMID 23403942PMCID PMC3625750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients

  2012cited by this paper
• Ubiquitin-Specific Protease 2 Regulates Hepatic Gluconeogenesis and Diurnal Glucose Metabolism Through 11β-Hydroxysteroid Dehydrogenase 1

  2012cited by this paper
• 11 b-Hydroxysteroid dehydrogenase type 1 : potential therapeutic target for metabolic syndrome

  2012cited by this paper
• Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2

  2012cited by this paper
• Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs.

  2011cited by this paper
• Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition

  2011cited by this paper
• Is metabolic syndrome a mild form of Cushing’s syndrome?

  2010cited by this paper
• Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.

  2010cited by this paper
• Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy

  2010cited by this paper
• Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.

  2010cited by this paper
• Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans

  2009cited by this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle

  2009cited by this paper
• Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.

  2009cited by this paper
• Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo

  2009cited by this paper
• Alteration of 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in a rat model of type 2 diabetes

  2008cited by this paper
• Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant?

  2008cited by this paper
• Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.

  2008cited by this paper
• Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.

  2007cited by this paper
• Extra-adrenal regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning

  2007cited by this paper
• Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease

  2006cited by this paper
• Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.

  2006cited by this paper
• Splanchnic Cortisol Production in Dogs Occurs Primarily in the Liver

  2006cited by this paper
• Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.

  2006cited by this paper
• Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs.

  2005cited by this paper
• Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis.

  2005cited by this paper
• Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

  2004cited by this paper
• Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway.

  2004cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

  2004cited by this paper
• Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.

  2004cited by this paper
• Lack of contribution of 11betaHSD1 and glucocorticoid action to reduced muscle mass associated with reduced growth hormone action.

  2004cited by this paper
• Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins.

  2004cited by this paper
• Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.

  2004cited by this paper
• Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

  2004cited by this paper
• Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs.

  2004cited by this paper
• Effects of hyperglycemia on hepatic gluconeogenic flux during glycogen phosphorylase inhibition in the conscious dog.

  2004cited by this paper
• Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.

  2003cited by this paper
• Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog.

  2003cited by this paper
• Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

  2003cited by this paper
• A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models

  2003cited by this paper
• Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians.

  2003cited by this paper
• Direct and indirect effects of insulin on glucose uptake and storage by the liver.

  2002cited by this paper
• Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.

  2002cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism.

  2001cited by this paper
• Rapid reversal of the effects of the portal signal under hyperinsulinemic conditions in the conscious dog.

  1999cited by this paper
• Rapid reversal of the effects of the portal signal under hyperinsulinemic conditions in the conscious dog.

  1999cited by this paper
• Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

  1997cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog.

  1996cited by this paper
• Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

  1996cited by this paper
• Effects of chronic elevation in plasma cortisol on hepatic carbohydrate metabolism.

  1993cited by this paper
• The Metabolic Response to Stress: An Overview and Update

  1990cited by this paper
• Regulation of the hepatic response to glucagon: role of insulin, growth hormone and cortisol.

  1989cited by this paper
• Insulin-counteracting hormones: Their impact on glucose metabolism

  1983cited by this paper
• Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

  1982cited by this paper
• Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle.

  1981cited by this paper
• Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans.

  1981cited by this paper
• Effect of dexamethasone and cortisone on insulin receptors in normal human male.

  1980cited by this paper
• Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

  1979cited by this paper
• Interaction of glucocorticoids with glucagon and epinephrine in the control of gluconeogenesis and glycogenolysis in liver and of lipolysis in adipose tissue.

  1972cited by this paper
• Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method.

  1971cited by this paper
• Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.

  1969cited by this paper
• Measurement of size and turnover rate of body glucose pool by the isotope dilution method.

  1956cited by this paper

• Computational QSAR study of novel 2-aminothiazol-4(5H)-one derivatives as 11β‐HSD1 inhibitors

  2025cites this paper
• Gluconeogenesis Flux in Metabolic Disease.

  2023cites this paper
• Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as Potential Drugs for Type 2 Diabetes Mellitus—A Systematic Review of Clinical and In Vivo Preclinical Studies

  2021cites this paper
• A review of the processed Polygonum multiflorum (Thunb.) for hepatoprotection: Clinical use, pharmacology and toxicology.

  2020cites this paper
• Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men

  2020cites this paper
• Risks and benefits of corticosteroids in arthritic diseases in the clinic.

  2019cites this paper
• Pentacyclic triterpenes: New tools to fight metabolic syndrome.

  2018cites this paper
• Glutamine dipeptide and cortisol change the liver glucose metabolism and reduce the severity of insulin-induced hypoglycaemia in untreated T1DM Swiss mice

  2017cites this paper
• Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

  2016cites this paper
• Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.

  2015cites this paper
• Normal cortisol response to cold pressor test, but lower free thyroxine, after recovery from undernutrition

  2015cites this paper
• Longitudinal changes in glucocorticoid metabolism are associated with later development of adverse metabolic phenotype.

  2014cites this paper
• Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

  2014cites this paper
• Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis

  2014cites this paper
• Obesity due to stress: A change in glucose and lipid metabolism due to altered cortisol levels

  2014cites this paper